Evidence map›Paper›PMID 38594502›Full record

ArticleNature protocols2024

Control of DNA replication in vitro using a reversible replication barrier.

Emma J Vontalge, Tamar Kavlashvili, Steven N Dahmen, Matthew T Cranford, James M Dewar

Open access · greenAbstract read
In one paragraph

Article in Nature protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Mitotic kinase regulation of DNA replication forks.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Emma J Vontalge *Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, USA.
Tamar Kavlashvili *Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, USA.
Steven N DahmenDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, USA.
Matthew T CranfordDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, USA.
James M DewarDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, USA. James.Dewar@vanderbilt.edu.ORCID 0000-0003-4153-3818
Vanderbilt University · US

Funding

TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGYT32ES007028 · NIEHS · VANDERBILT UNIVERSITY · PI F PETER Guengerich, Fiona Edith Harrison · 1985 to 2026
$15.7M
Mechanisms of replication fork degradation in vertebratesR01ES034847 · NIEHS · VANDERBILT UNIVERSITY · PI James M Dewar · 2023 to 2026
$1.9M
Investigation of strand-specific DNA replication stress response mechanisms.F32GM148024 · NIGMS · VANDERBILT UNIVERSITY · PI CRANFORD, MATTHEW · 2022 to 2022
$67k
NIEHS NIH HHS R01 ES034847NIEHS NIH HHS T32 ES007028NIGMS NIH HHS F32 GM148024U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences (NIEHS) R01ES034847U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences (NIEHS) T32ES007028U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) F32GM148024
6 · The paper itself

Abstract

A major obstacle to studying DNA replication is that it involves asynchronous and highly delocalized events. A reversible replication barrier overcomes this limitation and allows replication fork movement to be synchronized and localized, facilitating the study of replication fork function and replication coupled repair. Here we provide details on establishing a reversible replication barrier in vitro and using it to monitor different aspects of DNA replication. DNA template containing an array of lac operator (lacO) sequences is first bound to purified lac repressor (LacR). This substrate is then replicated in vitro using a biochemical replication system, which results in replication forks stalled on either side of the LacR array regardless of when or where they arise. Once replication forks are synchronized at the barrier, isopropyl-β-D-thiogalactopyranoside can be added to disrupt LacR binding so that replication forks synchronously resume synthesis. We describe how this approach can be employed to control replication fork elongation, termination, stalling and uncoupling, as well as assays that can be used to monitor these processes. We also explain how this approach can be adapted to control whether replication forks encounter a DNA lesion on the leading or lagging strand template and whether a converging fork is present. The required reagents can be prepared in 1-2 weeks and experiments using this approach are typically performed over 1-3 d. The main requirements for utilizing the LacR replication barrier are basic biochemical expertise and access to an in vitro system to study DNA replication. Investigators should also be trained in working with radioactive materials.

Indexed as

DNA ReplicationDNALac RepressorsDNALac Repressors

Identifiers

PMID38594502
PMCPMC11230854
OpenAlexW4394604099

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.